Siddhartha Ganguly, MD, FACP

Carol Cockrell Curran Distinguished Centennial Chief in Hematologic Oncology, Dr. Mary and Ron Neal Cancer Center
Professor of Clinical Oncology, Academic Institute
Full Clinical Member, Research Institute
Houston Methodist


Biography

Dr. Ganguly is a board-certified hematologist specializing in the clinical care and research of hematological malignancies, cellular therapeutics, and bone marrow transplantation. Dr. Ganguly was a A. Drue Jennings endowed professor of medical oncology at the University of Kansas Cancer Center in Westwood, Kansas where he was also the Deputy Director of the Division of Hematological Malignancies and Cellular Therapeutics, the Associate Director of Blood and Marrow Transplantation Program, and the Director of Lymphoma and Myeloma Program.

Dr. Ganguly received his undergraduate degree from Calcutta Medical College and his medical degree from the Department of Internal Medicine, Post Graduate, Institute of Medical Education and Research in India. Additionally, he completed his residency in internal medicine and fellowship in hematology at Baylor College of Medicine and concluded another fellowship in bone marrow transplantation at Baylor College of Medicine, Center for Cell and Gene Therapy.

Publications

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
Balmaceda, N, Aziz, M, Chandrasekar, VT, McClune, B, Kambhampati, S, Shune, L, Abdallah, AO, Anwer, F, Majeed, A, Qazilbash, M, Ganguly, S, McGuirk, J & Mohyuddin, GR 2021, , BMC Cancer, vol. 21, no. 1, 730. https://doi.org/10.1186/s12885-021-08451-x

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States
Bhatt, NS, Brazauskas, R, Salit, RB, Syrjala, K, Bo-Subait, S, Tecca, H, Badawy, SM, Baker, KS, Beitinjaneh, A, Bejanyan, N, Byrne, M, Dias, A, Farhadfar, N, Freytes, CO, Ganguly, S, Hashmi, S, Hayashi, RJ, Hong, S, Inamoto, Y, Jamani, K, Kasow, KA, Khera, N, Krem, MM, Lazarus, HM, Lee, CJ, Lee, S, Majhail, NS, Malone, AK, Marks, DI, Mau, LW, Mayo, SJ, Muffly, LS, Nathan, S, Nishihori, T, Page, KM, Preussler, J, Rangarajan, HG, Rotz, SJ, Salooja, N, Savani, BN, Schears, R, Schechter-Finkelstein, T, Schiller, G, Shah, AJ, Sharma, A, Wang, T, Wirk, B, Battiwalla, M, Schoemans, H, Hamilton, B, Buchbinder, D, Phelan, R & Shaw, B 2021, , Transplantation and Cellular Therapy, vol. 27, no. 8, pp. 679.e1-679.e8. https://doi.org/10.1016/j.jtct.2021.04.013

Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation
Mulroney, CM, Bilal Abid, M, Bashey, A, Chemaly, RF, Ciurea, SO, Chen, M, Dandoy, CE, Diaz Perez, MA, Friend, BD, Fuchs, E, Ganguly, S, Goldsmith, SR, Kanakry, CG, Kim, S, Komanduri, KV, Krem, MM, Lazarus, HM, Ljungman, P, Maziarz, R, Nishihori, T, Patel, SS, Perales, MA, Romee, R, Singh, AK, Reid Wingard, J, Yared, J, Riches, M & Taplitz, R 2021, , British Journal of Haematology, vol. 194, no. 1, pp. 145-157. https://doi.org/10.1111/bjh.17563

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
CIBMTR Infection and Immune Reconstitution Working Committee 2021, , Blood, vol. 137, no. 23, pp. 3291-3305. https://doi.org/10.1182/blood.2020009362

Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy
Hoffmann, MS & Ganguly, S 2021, , Clinical Lymphoma, Myeloma and Leukemia, vol. 21, no. 6, pp. e548-e550. https://doi.org/10.1016/j.clml.2021.02.009

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation: N. Farhadfar et al
Farhadfar, N, Dias, A, Wang, T, Fretham, C, Chhabra, S, Murthy, HS, Broglie, L, DSouza, A, Gadalla, SM, Gale, RP, Hashmi, S, Al-Homsi, AS, Hildebrandt, GC, Hematti, P, Rizzieri, D, Chee, L, Lazarus, HM, Bredeson, C, Jaimes, EA, Beitinjaneh, A, Bashey, A, Prestidge, T, Krem, MM, Marks, DI, Benoit, S, Yared, JA, Nishihori, T, Olsson, RF, Freytes, CO, Stadtmauer, E, Savani, BN, Sorror, ML, Ganguly, S, Wingard, JR & Pasquini, M 2021, , Transplantation and Cellular Therapy, vol. 27, no. 5, pp. 410-422. https://doi.org/10.1016/j.jtct.2021.02.030

Preclinical evaluation of gilteritinib on NPM1-ALK-driven anaplastic large cell lymphoma cells
Kuravi, S, Cheng, J, Fangman, G, Polireddy, K, McCormick, S, Lin, TL, Singh, AK, Abhyankar, S, Ganguly, S, Welch, DR, Jensen, RA, McGuirk, JP & Balusu, R 2021, , Molecular Cancer Research, vol. 19, no. 5, pp. 913-920. https://doi.org/10.1158/1541-7786.MCR-20-0738

Correction: Allogeneic transplantation in elderly patients =65 years with non-Hodgkin lymphoma: a time-trend analysis (Blood Cancer Journal, (2019), 9, 12, (97), 10.1038/s41408-019-0261-1)
Shah, NN, Ahn, KW, Litovich, C, Sureda, A, Kharfan-Dabaja, MA, Awan, FT, Ganguly, S, Gergis, U, Inwards, D, Karmali, R, Lazaryan, A, Lekakis, L, Munshi, P, Nathan, S, Saad, AA, Solh, M, Steinberg, A, Vij, R, Wood, WA, Fenske, TS, Smith, S & Hamadani, M 2021, , Blood Cancer Journal, vol. 11, no. 4, 82. https://doi.org/10.1038/s41408-021-00472-w

Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Kang, D, Ludwig, E, Jaworowicz, D, Huang, H, Fiedler-Kelly, J, Cortes, J, Ganguly, S, Khaled, S, Krämer, A, Levis, M, Martinelli, G, Perl, A, Russell, N, Abutarif, M, Choi, Y & Yin, O 2021, , Cancer Chemotherapy and Pharmacology, vol. 87, no. 4, pp. 513-523. https://doi.org/10.1007/s00280-020-04204-y

Peri-transplant extracorporeal photopheresis to mitigate GVHD- a pilot clinical trial
Abdelhakim, H, Accurso, A, Merkel, D, Dejarnette, S, Aljitawi, O, Yankee, T, He, J, Ganguly, S, McGuirk, J & Abhyankar, S 2021, , Bone Marrow Transplantation, vol. 56, no. 4, pp. 980-982. https://doi.org/10.1038/s41409-020-01142-4

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
Hong, S, Brazauskas, R, Hebert, KM, Ganguly, S, Abdel-Azim, H, Diaz, MA, Beattie, S, Ciurea, SO, Szwajcer, D, Badawy, SM, Gratwohl, AA, LeMaistre, C, Aljurf, MDSM, Olsson, RF, Bhatt, NS, Farhadfar, N, Yared, JA, Yoshimi, A, Seo, S, Gergis, U, Beitinjaneh, AM, Sharma, A, Lazarus, H, Law, J, Ulrickson, M, Hashem, H, Schoemans, H, Cerny, J, Rizzieri, D, Savani, BN, Kamble, RT, Shaw, BE, Khera, N, Wood, WA, Hashmi, S, Hahn, T, Lee, SJ, Rizzo, JD, Majhail, NS & Saber, W 2021, , Cancer, vol. 127, no. 4, pp. 609-618. https://doi.org/10.1002/cncr.33232

Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis (Bone Marrow Transplantation, (2020), 55, 11, (2121-2131), 10.1038/s41409-020-0911-8)
Farhadfar, N, Murthy, HS, Logan, BR, Sees, JA, Ayas, M, Battiwalla, M, Beitinjaneh, AM, Chhabra, S, Diaz, MA, Engles, K, Frangoul, H, Ganguly, S, Gergis, U, Kamani, NR, Kamble, RT, Kasow, KA, Lazarus, HM, Liesveld, JL, Norkin, M, O’ Donnell, PV, Olsson, RF, Rossmann, S, Savani, BN, Schears, R, Seo, S, Solh, MM, Spitzer, T, Sugrue, M, Yared, JA, Linenberger, M, Schwartz, J, Pulsipher, MA, Shah, NN, Switzer, GE, Confer, DL, Shaw, BE & Wingard, JR 2021, , Bone Marrow Transplantation, vol. 56, no. 2, pp. 522. https://doi.org/10.1038/s41409-020-0963-9

High-level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome
Gao, L, Saeed, A, Golem, S, Zhang, D, Woodroof, J, McGuirk, J, Ganguly, S, Abhyankar, S, Lin, TL & Cui, W 2021, , International Journal of Laboratory Hematology, vol. 43, no. 1, pp. 99-109. https://doi.org/10.1111/ijlh.13316

Outcomes of VD-PACE With Immunomodulatory Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma
Abdallah, AO, Sigle, M, Mohyuddin, GR, Coggins, E, Remker, C, Shune, L, Mahmoudjafari, Z, McGuirk, J & Ganguly, S 2021, , Clinical Lymphoma, Myeloma and Leukemia, vol. 21, no. 2, pp. e220-e226. https://doi.org/10.1016/j.clml.2020.09.002

Outcomes of Daratumumab, Pomalidomide, and Dexamethasone, Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation, in Patients With Relapsed/Refractory Multiple Myeloma
Abdallah, AO, Mohyuddin, GR, Mahmoudjafari, Z, Atrash, S, Kawsar, H, Sigle, M, Shune, L, McGuirk, J & Ganguly, S 2021, , Clinical Lymphoma, Myeloma and Leukemia, vol. 21, no. 2, pp. e212-e219. https://doi.org/10.1016/j.clml.2020.08.026

WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1
Li, M, Soder, R, Abhyankar, S, Abdelhakim, H, Braun, MW, Trinidad, CV, Pathak, HB, Pessetto, Z, Deighan, C, Ganguly, S, Dawn, B, McGuirk, J, Dunavin, N & Godwin, AK 2021, , Journal of Extracellular Vesicles, vol. 10, no. 4, e12067. https://doi.org/10.1002/jev2.12067

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: A CIBMTR analysis
Bona, K, Brazauskas, R, He, N, Lehmann, L, Abdel-Azim, H, Ahmed, IA, Al-Homsi, AS, Aljurf, M, Arnold, SD, Badawy, SM, Battiwalla, M, Beattie, S, Bhatt, NS, Dalal, J, Dandoy, CE, Diaz, MA, Frangoul, HA, Freytes, CO, Ganguly, S, George, B, Gomez-Almaguer, D, Hahn, T, Kamble, RT, Knight, JM, LeMaistre, CF, Law, J, Lazarus, HM, Majhail, NS, Olsson, RF, Preussler, J, Savani, BN, Schears, R, Seo, S, Sharma, A, Srivastava, A, Steinberg, A, Szwajcer, D, Wirk, B, Yoshimi, A, Khera, N, Wood, WA, Hashmi, S, Duncan, CN & Saber, W 2021, , Blood, vol. 137, no. 4, pp. 556-568. https://doi.org/10.1182/blood.2020006252

Maintenance regimens after a second autologous transplant for multiple myeloma
Mohyuddin, GR, Okoniewski, M, Diab, O, Ganguly, S, Shune, L, Abdallah, AO, McGuirk, J & McClune, B 2021, , Leukemia and Lymphoma, vol. 62, no. 3, pp. 758-760. https://doi.org/10.1080/10428194.2020.1842402

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Percival, ME, Wang, HL, Zhang, MJ, Saber, W, de Lima, M, Litzow, M, Kebriaei, P, Abdel-Azim, H, Adekola, K, Aljurf, M, Bacher, U, Badawy, SM, Beitinjaneh, A, Bejanyan, N, Bhatt, V, Byrne, M, Cahn, JY, Castillo, P, Chao, N, Chhabra, S, Copelan, E, Cutler, C, DeFilipp, Z, Dias, A, Diaz, MA, Estey, E, Farhadfar, N, Frangoul, HA, Freytes, CO, Gale, RP, Ganguly, S, Gowda, L, Grunwald, M, Hossain, N, Kamble, RT, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Krem, M, Lazarus, HM, Lee, JW, Liesveld, JL, Lin, R, Liu, H, McGuirk, J, Munker, R, Murthy, HS, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Passweg, JR, Prestidge, T, Ringdén, O, Rizzieri, DA, Rybka, WB, Savoie, ML, Schultz, KR, Seo, S, Sharma, A, Solh, M, Strair, R, van der Poel, M, Verdonck, LF, Yared, JA, Weisdorf, D & Sandmaier, BM 2021, , Bone Marrow Transplantation, vol. 56, no. 9, pp. 2108-2117. https://doi.org/10.1038/s41409-021-01261-6

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation (Bone Marrow Transplantation, (2021), 56, 9, (2108-2117), 10.1038/s41409-021-01261-6)
Percival, ME, Wang, HL, Zhang, MJ, Saber, W, de Lima, M, Litzow, M, Kebriaei, P, Abdel-Azim, H, Adekola, K, Aljurf, M, Bacher, U, Badawy, SM, Beitinjaneh, A, Bejanyan, N, Bhatt, V, Byrne, M, Cahn, JY, Castillo, P, Chao, N, Chhabra, S, Copelan, E, Cutler, C, DeFilipp, Z, Dias, A, Diaz, MA, Estey, E, Farhadfar, N, Frangoul, HA, Freytes, CO, Gale, RP, Ganguly, S, Gowda, L, Grunwald, M, Hossain, N, Kamble, RT, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Krem, M, Lazarus, HM, Lee, JW, Liesveld, JL, Lin, R, Liu, H, McGuirk, J, Munker, R, Murthy, HS, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Passweg, JR, Prestidge, T, Ringdén, O, Rizzieri, DA, Rybka, WB, Savoie, ML, Schultz, KR, Seo, S, Sharma, A, Solh, M, Strair, R, van der Poel, M, Verdonck, LF, Yared, JA, Weisdorf, D & Sandmaier, BM 2021, , Bone Marrow Transplantation, vol. 56, no. 9, pp. 2319. https://doi.org/10.1038/s41409-021-01353-3